{"count":159558,"next":"https://api-test.medunigraz.at/v1/research/publication/?format=json&limit=20&offset=157980&ordering=-impactfactor_norm","previous":"https://api-test.medunigraz.at/v1/research/publication/?format=json&limit=20&offset=157940&ordering=-impactfactor_norm","results":[{"id":177265,"title":"[Are Higher Prices for Larger Femoral Heads in Total Hip Arthroplasty Justified from the Perspective of Health Care Economics? An Analysis of Costs and Effects in Germany].","abstract":null,"authors":["Grunert, R","Schleifenbaum, S","Möbius, R","Sommer, G","Zajonz, D","Hammer, N","Prietzel, T"],"year":2017,"source":"Z Orthop Unfall. 2017; 155(1):52-60","category":1,"document_type":1,"sci":"ISI:000396282000014","pubmed":"27716867","doi":"10.1055/s-0042-113003","pmc":null,"organizations":[],"persons":["177265-102804-6"],"imported":"2019-10-03T02:00:00+02:00","journal":"Z Orthop Unfall","issn":"1864-6697","collection_publisher":null,"collection_title":null,"edition":null,"university":null,"country":null,"case_report":false,"impactfactor":0.572,"impactfactor_year":2017,"impactfactor_norm":0.091,"impactfactor_norm_year":2017,"impactfactor_norm_category":"ORTHOPEDICS-SCI","impactfactor_norm_super":0.145,"impactfactor_norm_super_year":2016,"impactfactor_norm_super_category":"ORTHOPEDICS-SCI","citations":true,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":false},{"id":183915,"title":"Retrospective analysis of treatment pathways in patients with BRAF(V600E)-mutant metastatic colorectal carcinoma - MORSECRC.","abstract":null,"authors":["Gerger, A","Eisterer, W","Fuxius, S","Bastian, S","Koeberle, D","Welslau, M","Akhoundova, D","Maas, C","Uhlig, J","Fenchel, K","Greil, R","von der Heyde, E","Agocs, R","Weide, R","Modest, DP","Fritsch, R"],"year":2020,"source":"ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):131-131.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND. ","category":2,"document_type":9,"sci":"ISI:000575955000302","pubmed":null,"doi":null,"pmc":null,"organizations":["183915-14085"],"persons":["183915-58814"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":true,"conference_place":true,"conference_international":true,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":183553,"title":"Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome","abstract":null,"authors":["Uhl, B","Prochazka, K","Wenzl, K","Hatzl, S","Greinix, HT","Beham-Schmid, C","Neumeister, P","Deutsch, A"],"year":2019,"source":"ONCOL RES TREAT. 2019; 42: 83-83.","category":2,"document_type":9,"sci":"ISI:000568159600198","pubmed":null,"doi":null,"pmc":null,"organizations":["183553-14020","183553-14082"],"persons":["183553-51930","183553-59183","183553-94596","183553-54230"],"imported":"2020-10-06T12:02:36+02:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2019,"impactfactor_norm":0.091,"impactfactor_norm_year":2019,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":true,"bmf_use":false,"zmf_use":true,"local_affiliation":true},{"id":183560,"title":"Induction chemotherapy with Docetaxel, Cisplatin and Cetuximab results in improved response rates if compared to Docetaxel, Cisplatin and 5-FU for locally advanced or inoperable squamous cell carcinoma of the head and neck: promising results of the Austrian multicentric phase II trial (AGMT)","abstract":null,"authors":["Keil, F","Hartl, M","Altorjai, G","Pecherstorfer, M","Berghold, A","Riedl, R","De Vries, A","Mayrbaurl, B","Fridrik, MA","Fureder, T","Burian, M","Greil, R"],"year":2019,"source":"ONCOL RES TREAT. 2019; 42:  56-57. ","category":2,"document_type":9,"sci":"ISI:000568159600138","pubmed":null,"doi":null,"pmc":null,"organizations":["183560-14026"],"persons":["183560-51344","183560-59026"],"imported":"2020-10-06T12:02:36+02:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2019,"impactfactor_norm":0.091,"impactfactor_norm_year":2019,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":false},{"id":184016,"title":"FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.","abstract":null,"authors":["Riedl, J","Posch, F","Horvath, L","Gantschnigg, A","Renneberg, F","Schwarzenbacher, E","Moik, F","Barth, D","Schaberl-Moser, R","Stotz, M","Pichler, M","Stoger, H","Greil, R","Djanani, A","Schlick, K","Gerger, A"],"year":2020,"source":"ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215.","category":2,"document_type":9,"sci":"ISI:000575955000486","pubmed":null,"doi":null,"pmc":null,"organizations":["184016-14082","184016-14085"],"persons":["184016-111475","184016-51538","184016-51949","184016-58814","184016-66005","184016-91876","184016-92241"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":true,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":183972,"title":"The value of adoptive cell therapy and immunotherapy.","abstract":null,"authors":["Szkandera, J"],"year":2020,"source":"ONCOL RES TREAT. 2020; 43(SUPPL 4):10-10.-DGHO; OKT 09-12, 2021; Virtuell. ","category":2,"document_type":9,"sci":"ISI:000575955000030","pubmed":null,"doi":null,"pmc":null,"organizations":["183972-14085"],"persons":["183972-69234"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":true,"conference_place":true,"conference_international":true,"scientific_event":true,"invited_lecture":true,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":183563,"title":"Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer","abstract":null,"authors":["Riedl, JM","Barth, D","Posch, F","Foris, V","Absenger, G","Mollnar, S","Pichler, M","Stotz, M","Stoger, H","Olschewski, H","Gerger, A"],"year":2019,"source":"ONCOL RES TREAT. 2019; 42:  115-115. ","category":2,"document_type":9,"sci":"ISI:000568159600275","pubmed":null,"doi":null,"pmc":null,"organizations":["183563-14085","183563-14087"],"persons":["183563-51538","183563-58814","183563-66005","183563-87980","183563-91876","183563-59304","183563-92241"],"imported":"2020-10-06T12:02:36+02:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2019,"impactfactor_norm":0.091,"impactfactor_norm_year":2019,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":true,"conference_place":true,"conference_international":true,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":183979,"title":"MAINTenance treatment post-ASCT of Myeloma patients documented IN the Austrian Myeloma registry - The MAINTAIN-project.","abstract":null,"authors":["Weger, R","Willenbacher, E","Agis, H","Krauth, M","Sormann, S","Bauer, F","Strassl, I","Willenbacher, W"],"year":2020,"source":"ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):112-113.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND. ","category":2,"document_type":9,"sci":"ISI:000575955000261","pubmed":null,"doi":null,"pmc":null,"organizations":["183979-14082"],"persons":["183979-52900"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":true,"conference_place":true,"conference_international":true,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":184015,"title":"Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.","abstract":null,"authors":["Schwarzenbacher, E","Moik, F","Horvath, L","Renneberg, F","Posch, F","Barth, D","Gantschnigg, A","Schaberl-Moser, R","Pichler, M","Stotz, M","Stoger, H","Ay, C","Greil, R","Gerger, A","Djanani, A","Schlick, K","Riedl, J"],"year":2020,"source":"ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214.","category":2,"document_type":9,"sci":"ISI:000575955000483","pubmed":null,"doi":null,"pmc":null,"organizations":["184015-14085"],"persons":["184015-111475","184015-51538","184015-51949","184015-58814","184015-66005","184015-91876","184015-92241"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":true,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":183522,"title":"Which therapies for which molecular subtypes?","abstract":null,"authors":["Szkandera, J"],"year":2019,"source":"ONCOL RES TREAT. 2019; 42:  239-240. ","category":2,"document_type":9,"sci":"ISI:000568159600578","pubmed":null,"doi":null,"pmc":null,"organizations":["183522-14085"],"persons":["183522-69234"],"imported":"2020-10-06T12:02:36+02:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2019,"impactfactor_norm":0.091,"impactfactor_norm_year":2019,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":false},{"id":183521,"title":"Hemophagocytic syndrome in aggressive NK-cell leukemia: case report and discussion","abstract":null,"authors":["Tinchon, C","Stelzer, I","Pichler, A","Mayer, D","Hofler, G","Enko, D"],"year":2019,"source":"ONCOL RES TREAT. 2019; 42: 258-258.-Annual Meeting of the German, Austrian and Swiss Society for Hematology and Medical Oncology; OCT 11-14, 2019; Berlin, GERMANY. ","category":2,"document_type":9,"sci":"ISI:000568159600623","pubmed":null,"doi":null,"pmc":null,"organizations":["183521-14028"],"persons":["183521-51159","183521-89193"],"imported":"2020-10-06T12:02:36+02:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2019,"impactfactor_norm":0.091,"impactfactor_norm_year":2019,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":true,"conference_place":true,"conference_international":true,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":false},{"id":183980,"title":"Exploring the multiple myeloma maintenance treatment landscape in Austria.","abstract":null,"authors":["Willenbacher, E","Agis, H","Krauth, M","Sormann, S","Weger, R","Bauer, F","Hartmann, B","Willenbacher, W"],"year":2020,"source":"ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):113-113.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND. ","category":2,"document_type":9,"sci":"ISI:000575955000262","pubmed":null,"doi":null,"pmc":null,"organizations":["183980-14082"],"persons":["183980-52900"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":true,"conference_place":true,"conference_international":true,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":169716,"title":"Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.","abstract":null,"authors":["Schochter, F","Rack, B","Tzschaschel, M","Polasik, A","Andergassen, U","Trapp, E","Alunni-Fabbroni, M","Schneeweiss, A","Müller, V","Pantel, K","Gade, J","Lorenz, R","Rezai, M","Tesch, H","Soeling, U","Fehm, T","Mahner, S","Schindlbeck, C","Lichtenegger, W","Beckmann, MW","Fasching, PA","Janni, W","Friedl, TWP","SUCCESS Study Group"],"year":2018,"source":"Oncol Res Treat. 2018; 41(3):93-98","category":1,"document_type":1,"sci":"ISI:000427011300001","pubmed":"29490302","doi":"10.1159/000485566","pmc":null,"organizations":[],"persons":["169716-76969-6"],"imported":"2018-10-15T02:00:00+02:00","journal":"Oncol Res Treat","issn":"2296-5262","collection_publisher":null,"collection_title":null,"edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2018,"impactfactor_norm":0.091,"impactfactor_norm_year":2018,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":0.194,"impactfactor_norm_super_year":2016,"impactfactor_norm_super_category":"ONCOLOGY-SCI","citations":true,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":false},{"id":183984,"title":"Tregs cells - a double edged sword? Lessons learned from colorectal cancer in comparison to type 1 diabetes mellitus.","abstract":null,"authors":["Bauernhofer, T","Stanzer, S","Prietl, B","Kofler, S","Obermayer-Pietsch, B","Pichler, M","Sourij, H","Pieber, T"],"year":2020,"source":"ONCOL RES TREAT. 2020; 43(SUPPL 4):127-128.","category":2,"document_type":9,"sci":"ISI:000575955000295","pubmed":null,"doi":null,"pmc":null,"organizations":["183984-14080","183984-14085"],"persons":["183984-50539","183984-50838","183984-51692","183984-51809","183984-51831","183984-56667"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":true,"invited_lecture":true,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":183985,"title":"Outcomes of relapsed/refractory multiple myeloma patients receiving carfilzomib-based therapy in routine practice; results of a single-centre Austrian registry.","abstract":null,"authors":["Sormann, S","Pasteiner, W","Kahangire, DA","Greinix, H"],"year":2020,"source":"ONCOL RES TREAT. 2020; 43(SUPPL 4):115-115.","category":2,"document_type":9,"sci":"ISI:000575955000267","pubmed":null,"doi":null,"pmc":null,"organizations":["183985-14082"],"persons":["183985-52900","183985-54230"],"imported":"2020-10-28T09:08:00+01:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2020,"impactfactor_norm":0.091,"impactfactor_norm_year":2020,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":true,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":true,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":183561,"title":"Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis","abstract":null,"authors":["Panny, M","Prochazka, K","Nosslinger, T","Neumeister, P","Holzer, K","Bohm, A","Keil, F"],"year":2019,"source":"ONCOL RES TREAT. 2019; 42:  82-82. ","category":2,"document_type":9,"sci":"ISI:000568159600195","pubmed":null,"doi":null,"pmc":null,"organizations":["183561-14082"],"persons":["183561-51930"],"imported":"2020-10-06T12:02:36+02:00","journal":"ONCOL RES TREAT","issn":"2296-5270","collection_publisher":null,"collection_title":"ONCOLOGY RESEARCH AND TREATMENT; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":1.483,"impactfactor_year":2019,"impactfactor_norm":0.091,"impactfactor_norm_year":2019,"impactfactor_norm_category":"ONCOLOGY-SCI","impactfactor_norm_super":null,"impactfactor_norm_super_year":null,"impactfactor_norm_super_category":null,"citations":false,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":false},{"id":203703,"title":"[Practical aspects of COVID-19 autopsies].","abstract":null,"authors":["Boor, P","Eichhorn, P","Hartmann, A","Lax, SF","Märkl, B","Menter, T","Skok, K","Slotta-Huspenina, J","von, Stillfried, S","Tzankov, A","Weirich, G"],"year":2021,"source":"Pathologe. 2021; 42(2): 197-207. ","category":1,"document_type":3,"sci":"ISI:000621242900001","pubmed":"33625535","doi":"10.1007/s00292-021-00925-w","pmc":"PMC7903213","organizations":[],"persons":["203703-120849-6","203703-52442-6"],"imported":"2023-07-11T02:00:00+02:00","journal":"Pathologe","issn":"1432-1963","collection_publisher":null,"collection_title":null,"edition":null,"university":null,"country":null,"case_report":false,"impactfactor":0.973,"impactfactor_year":2021,"impactfactor_norm":0.091,"impactfactor_norm_year":2021,"impactfactor_norm_category":"PATHOLOGY-SCI","impactfactor_norm_super":0.118,"impactfactor_norm_super_year":2018,"impactfactor_norm_super_category":"PATHOLOGY-SCI","citations":true,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":116685,"title":"Granular cell tumor of the stomach.","abstract":null,"authors":["Gilg, MM","Mrak, K","Vieth, M","Langner, C"],"year":2012,"source":"Pathologe. 2012; 33(1):61-64","category":1,"document_type":1,"sci":"ISI:000299750900009","pubmed":"22293791","doi":"10.1007/s00292-011-1547-7","pmc":null,"organizations":["116685-14020"],"persons":["116685-50044-4","116685-77074-1"],"imported":"2012-02-02T01:00:00+01:00","journal":"Pathologe","issn":"0172-8113","collection_publisher":null,"collection_title":null,"edition":null,"university":null,"country":null,"case_report":true,"impactfactor":0.621,"impactfactor_year":2012,"impactfactor_norm":0.091,"impactfactor_norm_year":2012,"impactfactor_norm_category":"PATHOLOGY","impactfactor_norm_super":0.114,"impactfactor_norm_super_year":2011,"impactfactor_norm_super_category":"PATHOLOGY","citations":true,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":186998,"title":"[Systemic consequences and clinical aspects of SARS-CoV-2 infection].","abstract":null,"authors":["Lax, SF","Skok, K","Zechner, PM","Setaffy, L","Kessler, HH","Kaufmann, N","Vander, K","Cokić, N","Maierhofer, U","Bargfrieder, U","Trauner, M"],"year":2021,"source":"PATHOLOGE. 2021; 42(2): 155-163. ","category":1,"document_type":3,"sci":"ISI:000617084800002","pubmed":"33575886","doi":"10.1007/s00292-021-00913-0","pmc":"PMC7877545","organizations":["186998-14020","186998-14023"],"persons":["186998-120849-6","186998-51812-6","186998-52442-2","186998-64334-6"],"imported":"2021-03-16T09:39:04+01:00","journal":"PATHOLOGE","issn":"0172-8113","collection_publisher":null,"collection_title":"PATHOLOGE; ","edition":null,"university":null,"country":null,"case_report":false,"impactfactor":0.973,"impactfactor_year":2021,"impactfactor_norm":0.091,"impactfactor_norm_year":2021,"impactfactor_norm_category":"PATHOLOGY-SCI","impactfactor_norm_super":0.118,"impactfactor_norm_super_year":2018,"impactfactor_norm_super_category":"PATHOLOGY-SCI","citations":true,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true},{"id":116684,"title":"Secondary tumors of the gastrointestinal tract.","abstract":null,"authors":["Langner, C"],"year":2012,"source":"Pathologe. 2012; 33(1):45-52","category":1,"document_type":1,"sci":"ISI:000299750900007","pubmed":"22293789","doi":"10.1007/s00292-011-1544-x","pmc":null,"organizations":["116684-14020"],"persons":["116684-50044-2"],"imported":"2012-02-02T01:00:00+01:00","journal":"Pathologe","issn":"0172-8113","collection_publisher":null,"collection_title":null,"edition":null,"university":null,"country":null,"case_report":false,"impactfactor":0.621,"impactfactor_year":2012,"impactfactor_norm":0.091,"impactfactor_norm_year":2012,"impactfactor_norm_category":"PATHOLOGY","impactfactor_norm_super":0.114,"impactfactor_norm_super_year":2011,"impactfactor_norm_super_category":"PATHOLOGY","citations":true,"conference_name":null,"conference_place":null,"conference_international":false,"scientific_event":false,"invited_lecture":false,"keynote_speaker":false,"selected_presentation":false,"biobank_use":false,"bmf_use":false,"zmf_use":false,"local_affiliation":true}]}